{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:16:17Z","timestamp":1789827377399,"version":"4.0.1"},"reference-count":84,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012515","name":"Cyrus Tang Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["no. 82072782"],"award-info":[{"award-number":["no. 82072782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["Grant No. SHDC12018X22, SHDC2020CR2009A and SHDC12020125"],"award-info":[{"award-number":["Grant No. SHDC12018X22, SHDC2020CR2009A and SHDC12020125"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["World Jnl Ped Surgery"],"accepted":{"date-parts":[[2021,5,21]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hepatoblastoma (HB) is a rare malignancy usually occurring in children under 3 years old. With advancements in surgical techniques and molecular biology, new treatments have been developed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data resources<\/jats:title>\n                  <jats:p>The recent literatures on new treatments, molecular mechanisms and clinical trials for HB were searched and reviewed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Surgical resection remains the main option for treatment of HB. Although complete resection is recommended, a resection with microscopical positive margins (R1) may have similar 5-year overall survival and 5-year event-free survival (EFS) rates after cisplatin chemotherapy and the control of metastasis, as only once described so far. Indocyanine green-guided surgery can help achieve precise resection. Additionally, associating liver partition and portal vein ligation for staged hepatectomy can rapidly increase future liver remnant volume compared with portal vein ligation or embolization. Cisplatin-containing chemotherapies slightly differ among the guidelines from the International Childhood Liver Tumors Strategy Group (SIOPEL), Children\u2019s Oncology Group (COG) and Chinese Anti-Cancer Association Pediatric Committee (CCCG), and the 3-year EFS rate of patients in SIOPEL and CCCG studies was recently shown to be higher than that in COG studies. Liver transplantation is an option for patients with unresectable HB, and successful cases of autologous liver transplantation have been reported. In addition, effective inhibitors of important targets, such as the mTOR (mammalian target of rapamycin) inhibitor rapamycin, \u03b2-catenin inhibitor celecoxib and EpCAM (epithelial cell adhesion molecule) inhibitor catumaxomab, have been demonstrated to reduce the activity of HB cells and to control metastasis in experimental research and clinical trials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These advances in surgical and medical treatment provide better outcomes for children with HB, and identifying novel targets may lead to the development of future targeted therapies and immunotherapies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/wjps-2020-000220","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T13:08:10Z","timestamp":1623157690000},"page":"e000220","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-0090","authenticated-orcid":false,"given":"Zhixue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"2025081809564709000_4.3.e000220.1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12029-017-0005-z","article-title":"Surgical resection for Hepatoblastoma-Updated survival outcomes","volume":"49","author":"Sunil","year":"2018","journal-title":"J Gastrointest Cancer"},{"key":"2025081809564709000_4.3.e000220.2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB"},{"key":"2025081809564709000_4.3.e000220.3","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/ans.13839","article-title":"Adult hepatoblastoma: a review of 47 cases","volume":"88","author":"Duan","year":"2018","journal-title":"ANZ J Surg"},{"key":"2025081809564709000_4.3.e000220.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.02.004"},{"key":"2025081809564709000_4.3.e000220.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30598-8"},{"key":"2025081809564709000_4.3.e000220.6","first-page":"733","article-title":"Expert consensus for Multidiscciplinary management of hepatoblastoma (CCCG-HB-2016)","volume":"38","year":"2017","journal-title":"Chin J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2665"},{"key":"2025081809564709000_4.3.e000220.8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12098-017-2301-9","article-title":"Management of hepatoblastoma: ICMR consensus document","volume":"84","author":"Agarwala","year":"2017","journal-title":"Indian J Pediatr"},{"key":"2025081809564709000_4.3.e000220.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.09.023"},{"key":"2025081809564709000_4.3.e000220.10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121944","article-title":"Surgical management of hepatoblastoma and recent advances","volume":"11","author":"Yang","year":"2019","journal-title":"Cancers"},{"key":"2025081809564709000_4.3.e000220.11","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jpedsurg.2017.08.031","article-title":"The role of pulmonary metastasectomy for hepatoblastoma in children with metastasis at diagnosis: results from the JPLT-2 study","volume":"52","author":"Hishiki","year":"2017","journal-title":"J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.4857"},{"key":"2025081809564709000_4.3.e000220.13","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26820","article-title":"Extreme hepatic resections for the treatment of advanced hepatoblastoma: are planned close margins an acceptable approach?","volume":"65","author":"Fonseca","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2025081809564709000_4.3.e000220.14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2018.10.013","article-title":"Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report","volume":"106","author":"Aronson","year":"2019","journal-title":"Eur J Cancer"},{"key":"2025081809564709000_4.3.e000220.15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jpedsurg.2004.01.035","article-title":"Association between surgical margins and long-term outcome in advanced hepatoblastoma","volume":"39","author":"Dicken","year":"2004","journal-title":"J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.16","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27479","article-title":"Results of surgical resections with positive margins for children with hepatoblastoma: case series from a single Asian center","volume":"66","author":"Ren","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"2025081809564709000_4.3.e000220.17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10147-019-01573-0","article-title":"Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study","volume":"25","author":"Ren","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"2025081809564709000_4.3.e000220.18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081215","article-title":"Fluorescence-Guided surgery for hepatoblastoma with indocyanine green","volume":"11","author":"Yamada","year":"2019","journal-title":"Cancers"},{"key":"2025081809564709000_4.3.e000220.19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00383-019-04458-5","article-title":"Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients","volume":"35","author":"Souzaki","year":"2019","journal-title":"Pediatr Surg Int"},{"key":"2025081809564709000_4.3.e000220.20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpedsurg.2015.01.014","article-title":"Clinical application of indocyanine green (ICG) fluorescent imaging of hepatoblastoma","volume":"50","author":"Yamamichi","year":"2015","journal-title":"J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1089\/lap.2017.0735","article-title":"Metastasectomy of hepatoblastoma utilizing a novel overlay fluorescence imaging system","volume":"28","author":"Yamada","year":"2018","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"2025081809564709000_4.3.e000220.22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050730","article-title":"Living donor liver re-transplantation for recurrent hepatoblastoma in the liver graft following complete eradication of peritoneal metastases under indocyanine green fluorescence imaging","volume":"11","author":"Takahashi","year":"2019","journal-title":"Cancers"},{"key":"2025081809564709000_4.3.e000220.23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/icvts\/ivx247","article-title":"Clinical application of projection mapping technology for surgical resection of lung metastasis","volume":"25","author":"Chen-Yoshikawa","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2025081809564709000_4.3.e000220.24","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/SLA.0000000000002217","article-title":"Modified associating liver partition and portal vein ligation for staged hepatectomy for hepatoblastoma in a small infant: how far can we push the envelope?","volume":"266","author":"Hong","year":"2017","journal-title":"Ann Surg"},{"key":"2025081809564709000_4.3.e000220.25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.14701\/ahbps.2020.24.3.352","article-title":"A minimally invasive first stage of ALPPS for hepatoblastoma in a child","volume":"24","author":"Akhaladze","year":"2020","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2025081809564709000_4.3.e000220.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2513-3"},{"key":"2025081809564709000_4.3.e000220.27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jpedsurg.2014.10.019","article-title":"Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS) for the treatment of liver tumors in children","volume":"50","author":"Wiederkehr","year":"2015","journal-title":"J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.28","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjz144","article-title":"Monosegmental ALPPS: a long-term survival alternative to liver transplant in PRETEXT IV hepatoblastoma","volume":"2019","author":"Ruiz Figueroa","year":"2019","journal-title":"J Surg Case Rep"},{"key":"2025081809564709000_4.3.e000220.29","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.3748\/wjg.v20.i29.10208","article-title":"Little girl who conquered the \"ALPPS''","volume":"20","author":"Chan","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025081809564709000_4.3.e000220.30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.21037\/atm.2016.10.01","article-title":"Early multifocal recurrence of hepatoblastoma in the residual liver after R0 liver resection with ALPPS procedure: a case report","volume":"4","author":"Qazi","year":"2016","journal-title":"Ann Transl Med"},{"key":"2025081809564709000_4.3.e000220.31","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jpedsurg.2012.09.006","article-title":"Surgical strategies for unresectable hepatoblastomas","volume":"47","author":"Tajiri","year":"2012","journal-title":"J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2741\/e460","article-title":"Liver transplantation in the management of unresectable hepatoblastoma in children","volume":"4","author":"Meyers","year":"2012","journal-title":"Front Biosci"},{"key":"2025081809564709000_4.3.e000220.33","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1111\/j.1399-3046.2009.01262.x","article-title":"Successful treatment of unresectable advanced hepatoblastoma: living liver transplantation after surgical removal of lung metastasis","volume":"15","author":"Miyamura","year":"2011","journal-title":"Pediatr Transplant"},{"key":"2025081809564709000_4.3.e000220.34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0000000000001936","article-title":"POST-TEXT III and IV hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases","volume":"266","author":"Fuchs","year":"2017","journal-title":"Ann Surg"},{"key":"2025081809564709000_4.3.e000220.35","first-page":"5","article-title":"[Liver transplantation for hepatoblastoma in children]","author":"Filin","year":"2020","journal-title":"Khirurgiia"},{"key":"2025081809564709000_4.3.e000220.36","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13250","article-title":"Long-Term outcomes of liver transplantation for hepatoblastoma: a single-center 14-year experience","author":"Ramos-Gonzalez","year":"2018","journal-title":"Pediatr Transplant"},{"key":"2025081809564709000_4.3.e000220.37","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13268","article-title":"Ex vivo liver resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children: a case report","volume":"22","author":"Shi","year":"2018","journal-title":"Pediatr Transplant"},{"key":"2025081809564709000_4.3.e000220.38","first-page":"44","article-title":"Applicationantologous liver transplantation in complex infantile hepatoblastoma: a report of one case","volume":"39","author":"Zhang","year":"2018","journal-title":"Chin J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-200201150-00017","article-title":"Living-Related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma","volume":"73","author":"Chardot","year":"2002","journal-title":"Transplantation"},{"key":"2025081809564709000_4.3.e000220.40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.transproceed.2010.11.013","article-title":"Living related donor liver transplantation in children","volume":"43","author":"Tannuri","year":"2011","journal-title":"Transplant Proc"},{"key":"2025081809564709000_4.3.e000220.41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.14701\/ahbps.2019.23.2.178","article-title":"Pediatric living donor liver transplantation with homograft replacement of retrohepatic inferior vena cava for advanced hepatoblastoma","volume":"23","author":"Namgoong","year":"2019","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"2025081809564709000_4.3.e000220.42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00383-016-3893-2","article-title":"Usefulness of a Recanalized umbilical vein for vascular reconstruction in pediatric hepatic surgery","volume":"32","author":"Shinkai","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"2025081809564709000_4.3.e000220.43","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13409","article-title":"Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver transplantation for hepatoblastoma with caval extension","volume":"23","author":"Hort","year":"2019","journal-title":"Pediatr Transplant"},{"key":"2025081809564709000_4.3.e000220.44","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13221","article-title":"Pretransplant trends in \u03b1-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: a single-institution experience","volume":"22","author":"Isono","year":"2018","journal-title":"Pediatr Transplant"},{"key":"2025081809564709000_4.3.e000220.45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clon.2019.03.044","article-title":"Retrospective analysis of childhood hepatoblastoma in a single centre in China","volume":"31","author":"Wang","year":"2019","journal-title":"Clin Oncol"},{"key":"2025081809564709000_4.3.e000220.46","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the children's Oncology Group AHEP0731 study Committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"key":"2025081809564709000_4.3.e000220.47","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2017.73.5654","article-title":"Characterization of pulmonary metastases in children with hepatoblastoma treated on children's Oncology Group protocol AHEP0731 (the treatment of children with all stages of hepatoblastoma): a report from the children's Oncology Group","volume":"35","author":"O'Neill","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025081809564709000_4.3.e000220.48","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.3748\/wjg.v20.i18.5331","article-title":"Liver transplantation for malignancy: current treatment strategies and future perspectives","volume":"20","author":"Hackl","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025081809564709000_4.3.e000220.49","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000046"},{"key":"2025081809564709000_4.3.e000220.50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70272-9"},{"key":"2025081809564709000_4.3.e000220.51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.1110"},{"key":"2025081809564709000_4.3.e000220.52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.2319"},{"key":"2025081809564709000_4.3.e000220.53","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/MPH.0000000000001282","article-title":"Cisplatin-Induced ototoxicity in children with solid tumor","volume":"41","author":"Wei","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025081809564709000_4.3.e000220.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801109"},{"key":"2025081809564709000_4.3.e000220.55","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30625-8"},{"key":"2025081809564709000_4.3.e000220.56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2352-4642(19)30336-0","article-title":"Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline","volume":"4","author":"Freyer","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2025081809564709000_4.3.e000220.57","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24667"},{"key":"2025081809564709000_4.3.e000220.58","first-page":"57","article-title":"Research progress of PI3K\/Akt signaling pathway and malignant solid tumors in children","volume":"8","author":"Zhu","year":"2009","journal-title":"Chin J Pediatr Surg"},{"key":"2025081809564709000_4.3.e000220.59","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7398"},{"key":"2025081809564709000_4.3.e000220.60","first-page":"3181","article-title":"Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells","volume":"17","author":"Li","year":"2019","journal-title":"Oncol Lett"},{"key":"2025081809564709000_4.3.e000220.61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26668"},{"key":"2025081809564709000_4.3.e000220.62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147405"},{"key":"2025081809564709000_4.3.e000220.63","first-page":"4581","article-title":"miR\u2011378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, Pdgfr\u03b2 and c\u2011Raf","volume":"17","author":"Fu","year":"2018","journal-title":"Mol Med Rep"},{"key":"2025081809564709000_4.3.e000220.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2016.03.013"},{"key":"2025081809564709000_4.3.e000220.65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214469","article-title":"Pp2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HUH6 hepatoblastoma cells","volume":"14","author":"Stafman","year":"2019","journal-title":"PLoS One"},{"key":"2025081809564709000_4.3.e000220.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2014.11.019"},{"key":"2025081809564709000_4.3.e000220.67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep4.1029","article-title":"MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting \u03b2-catenin and Wnt signaling","volume":"1","author":"Indersie","year":"2017","journal-title":"Hepatol Commun"},{"key":"2025081809564709000_4.3.e000220.68","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-044010"},{"key":"2025081809564709000_4.3.e000220.69","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-012-3237-9"},{"key":"2025081809564709000_4.3.e000220.70","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2013.828085"},{"key":"2025081809564709000_4.3.e000220.71","doi-asserted-by":"publisher","DOI":"10.2174\/138945011795528796"},{"key":"2025081809564709000_4.3.e000220.72","doi-asserted-by":"publisher","DOI":"10.14670\/HH-29.881"},{"key":"2025081809564709000_4.3.e000220.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.024"},{"key":"2025081809564709000_4.3.e000220.74","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0206"},{"key":"2025081809564709000_4.3.e000220.75","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.21873\/anticanres.11143","article-title":"Therapeutic innovations for targeting hepatoblastoma","volume":"36","author":"Garnier","year":"2016","journal-title":"Anticancer Res"},{"key":"2025081809564709000_4.3.e000220.76","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22620","article-title":"Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma","volume":"2","author":"Armeanu-Ebinger","year":"2013","journal-title":"Oncoimmunology"},{"key":"2025081809564709000_4.3.e000220.77","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603494"},{"key":"2025081809564709000_4.3.e000220.78","doi-asserted-by":"crossref","unstructured":"CM O , Chon HJ , Kim C . Combination immunotherapy using oncolytic virus for the treatment of advanced solid tumors. Int J Mol Sci 2020;21.doi:10.3390\/ijms21207743","DOI":"10.3390\/ijms21207743"},{"key":"2025081809564709000_4.3.e000220.79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00108"},{"key":"2025081809564709000_4.3.e000220.80","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1377872","article-title":"Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors","volume":"7","author":"Tsuchiya","year":"2017","journal-title":"Oncoimmunology"},{"key":"2025081809564709000_4.3.e000220.81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00248","article-title":"Next-Generation cancer immunotherapy targeting glypican-3","volume":"9","author":"Shimizu","year":"2019","journal-title":"Front Oncol"},{"key":"2025081809564709000_4.3.e000220.82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2016.04.004","article-title":"Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma","volume":"65","author":"Abou-Alfa","year":"2016","journal-title":"J Hepatol"},{"key":"2025081809564709000_4.3.e000220.83","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5472-0","article-title":"Case-Control Indian buffet process identifies biomarkers of response to Codrituzumab","volume":"19","author":"Pradier","year":"2019","journal-title":"BMC Cancer"},{"key":"2025081809564709000_4.3.e000220.84","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00280-017-3241-9","article-title":"Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)","volume":"79","author":"Abou-Alfa","year":"2017","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["World Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/wjps-2020-000220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T16:57:01Z","timestamp":1755536221000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjps.bmj.com\/lookup\/doi\/10.1136\/wjps-2020-000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6,8]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/wjps-2020-000220"],"URL":"https:\/\/doi.org\/10.1136\/wjps-2020-000220","relation":{},"ISSN":["2516-5410"],"issn-type":[{"value":"2516-5410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}